Literature DB >> 32500249

Childhood risk factors for adulthood chronic kidney disease.

Michal Stern-Zimmer1,2, Ronit Calderon-Margalit3, Karl Skorecki4, Asaf Vivante5,6,7.   

Abstract

Chronic kidney disease (CKD) is a major public health challenge, affecting as much as 8 to 18% of the world population. Identifying childhood risk factors for future CKD may help clinicians make early diagnoses and initiation of preventive interventions for CKD and its attendant comorbidities as well as monitoring for complications. The purpose of this review is to describe childhood risk factors that may predict development of overt kidney disease later in life. Currently, there are multiple childhood risk factors associated with future onset and progression of CKD. These risk factors can be grouped into five categories: genetic factors (e.g., monogenic or risk alleles), perinatal factors (e.g., low birth weight and prematurity), childhood kidney diseases (e.g., congenital anomalies, glomerular diseases, and renal cystic ciliopathies), childhood onset of chronic conditions (e.g., cancer, diabetes, hypertension, dyslipidemia, and obesity), and different lifestyle factors (e.g., physical activity, diet, and factors related to socioeconomic status). The available published information suggests that the lifelong risk for CKD can be attributed to multiple factors that appear already during childhood. However, results are conflicting on the effects of childhood physical activity, diet, and dyslipidemia on future renal function. On the other hand, there is consistent evidence to support follow-up of high-risk groups.

Entities:  

Keywords:  Chronic kidney disease; End stage kidney disease

Mesh:

Year:  2020        PMID: 32500249     DOI: 10.1007/s00467-020-04611-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  83 in total

Review 1.  Screening for CKD in children: a global controversy.

Authors:  Ronald J Hogg
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

Review 2.  Rare inherited kidney diseases: challenges, opportunities, and perspectives.

Authors:  Olivier Devuyst; Nine V A M Knoers; Giuseppe Remuzzi; Franz Schaefer
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

3.  Population-based screening for family history of end-stage renal disease among incident dialysis patients.

Authors:  Barry I Freedman; Nataliya V Volkova; Scott G Satko; Jenna Krisher; Claudine Jurkovitz; J Michael Soucie; William M McClellan
Journal:  Am J Nephrol       Date:  2005-09-21       Impact factor: 3.754

Review 4.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

Review 5.  Rare and common variants: twenty arguments.

Authors:  Greg Gibson
Journal:  Nat Rev Genet       Date:  2012-01-18       Impact factor: 53.242

6.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

Review 7.  Familial clustering of chronic kidney disease.

Authors:  Scott G Satko; John R Sedor; Sudha K Iyengar; Barry I Freedman
Journal:  Semin Dial       Date:  2007 May-Jun       Impact factor: 3.455

8.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

9.  Age and association of kidney measures with mortality and end-stage renal disease.

Authors:  Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

10.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Authors:  Josef Coresh; Tanvir Chowdhury Turin; Ron T Gansevoort; Andrew S Levey; Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Lawrence J Appel; Hisatomi Arima; Steven J Chadban; Massimo Cirillo; Ognjenka Djurdjev; Jamie A Green; Gunnar H Heine; Lesley A Inker; Fujiko Irie; Areef Ishani; Joachim H Ix; Csaba P Kovesdy; Angharad Marks; Takayoshi Ohkubo; Varda Shalev; Anoop Shankar; Chi Pang Wen; Paul E de Jong; Kunitoshi Iseki; Benedicte Stengel
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272

View more
  4 in total

1.  Chronic kidney disease causes and outcomes in children: Perspective from a LMIC setting.

Authors:  Farhana Amanullah; Amyn A Malik; Zafar Zaidi
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

Review 2.  The genetic basis of congenital anomalies of the kidney and urinary tract.

Authors:  Maayan Kagan; Oren Pleniceanu; Asaf Vivante
Journal:  Pediatr Nephrol       Date:  2022-02-04       Impact factor: 3.651

3.  Risk stratification for children with a solitary functioning kidney.

Authors:  Sander Groen In't Woud; Loes F M van der Zanden; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2021-11       Impact factor: 3.714

4.  Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users.

Authors:  Arcelia Arrieta; Tadej Battelino; Andrea E Scaramuzza; Julien Da Silva; Javier Castañeda; Toni L Cordero; John Shin; Ohad Cohen
Journal:  Diabetes Obes Metab       Date:  2022-05-12       Impact factor: 6.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.